Is Carboxypeptidase B1 a Prognostic Marker for Ductal Carcinoma In Situ?

Is Carboxypeptidase B1 a Prognostic Marker for Ductal Carcinoma In Situ?

Ductal carcinoma in situ (DCIS) is considered a non-obligatory precursor for invasive ductal carcinoma (IDC). Around 70% of women with atypical ductal hyperplasia (ADH) undergo unnecessary surgery due to the difficulty in differentiating ADH from low-grade DCIS. If untreated, 14–60% of DCIS progress...

Full description

Bibliographic Details
Main Authors: Charu Kothari, Alisson Clemenceau, Geneviève Ouellette, Kaoutar Ennour-Idrissi, Annick Michaud, Caroline Diorio, Francine Durocher
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
breast cancer
DCIS
prognostic marker
ADH
IDC
human transcriptome array
Online Access:https://www.mdpi.com/2072-6694/13/7/1726

Internet

https://www.mdpi.com/2072-6694/13/7/1726

Similar Items